Foresee Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate

Latest as of June 2022: 0.70x

Foresee Pharmaceuticals Co Ltd cash flow reinvestment rate. Foresee Pharmaceuticals Co Ltd (6576) has a Cash Flow Reinvestment Rate of 0.70x as of June 2022, reinvesting NT$100.59 Million (capex NT$590.00K plus investments NT$100.00 Million) from operating cash flow of NT$143.03 Million. Explore Foresee Pharmaceuticals Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.70x

(Capex + Investments) / Operating CF

Total Reinvested

NT$100.59 Million

Capex + Investments

Operating Cash Flow

NT$143.03 Million

TWD

Capital Expenditures

NT$590.00K

TWD

Foresee Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (None–None)

Foresee Pharmaceuticals Co Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Foresee Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Foresee Pharmaceuticals Co Ltd cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (TWD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow